Ascendis Pharma AS (A71) — Cash Flow-to-Debt Ratio
Ascendis Pharma AS (A71) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of €-7.72 Million could theoretically repay 0% of its total liabilities (€1.52 Billion) in one year. See Ascendis Pharma AS free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ascendis Pharma AS Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Ascendis Pharma AS across 10 annual periods. Also explore net asset growth rate of Ascendis Pharma AS to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ascendis Pharma AS (2016–2025)
Year-by-year debt coverage analysis for Ascendis Pharma AS. For market capitalisation and broader financial context, see Ascendis Pharma AS market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | €53.90 Million | €1.47 Billion | ▲ +115.4% |
| 2024 | -0.24x | €-306.20 Million | €1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | €-467.36 Million | €971.28 Million | ▲ +19.8% |
| 2022 | -0.60x | €-495.70 Million | €826.39 Million | ▲ +71.1% |
| 2021 | -2.07x | €-417.65 Million | €201.29 Million | ▼ -7.8% |
| 2020 | -1.92x | €-271.55 Million | €141.08 Million | ▲ +12.9% |
| 2019 | -2.21x | €-175.94 Million | €79.62 Million | ▲ +38.0% |
| 2018 | -3.57x | €-138.80 Million | €38.92 Million | ▲ +10.9% |
| 2017 | -4.00x | €-95.10 Million | €23.77 Million | ▲ +10.5% |
| 2016 | -4.47x | €-60.18 Million | €13.46 Million | — |